Role of Senolytics in Lower Urinary Tract Aging and Voiding Disorders

Senolytics 在下尿路老化和排尿障碍中的作用

• 批准号: 9765752
• 负责人: GEORGE A KUCHEL
• 金额: $ 23.53万
• 依托单位: UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-15 至 2020-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9765752
• 关键词: Address; Admission activity; Affect; Age; Aged, 80 and over; Aging; Anesthesia procedures; Animals; Attenuated; Behavior; Biological; Biological Aging; Biological Assay; Bladder; Bladder Control; Bladder Dysfunction; Bladder Tissue; Brain; Brain Stem; Brain-Derived Neurotrophic Factor; Cardiac; Categories; Cells; Chemicals; Clinical; Cognition; Communication; Complex; Control Groups; DNA Damage; Dasatinib; Data; Development; Disease; Drug Combinations; Drug Targeting; Elderly; Exploratory/Developmental Grant; Frequencies; Functional disorder; Funding; Future; Genomics; Geroscience; Goals; Growth; Growth Factor; High Prevalence; Immune; Impairment; Incontinence; Individual; Lead; Link; Lower urinary tract; Measures; Mental Depression; Messenger RNA; Metabolic dysfunction; Micturition Reflex; Modeling; Mus; Natural History; Nature; Nerve; Neuregulin 1; Neuronal Plasticity; Nocturia; Nursing Homes; Pathway interactions; Patients; Pattern; Performance; Pharmaceutical Preparations; Pharmacotherapy; Phenotype; Physiological; Population; Prevention; Process; Publishing; Quality of life; Quercetin; Reproducibility; Risk Factors; Role; Science; Sensory; Signal Transduction; Smooth Muscle Myocytes; Stains; Stress; Symptoms; Syndrome; System; Technology; Testing; Therapeutic; Time; Tissues; Urethane; Urinary Incontinence; Urine; age group; age related; aged; awake; beta-Galactosidase; bone loss; cell type; density; experimental study; frailty; functional decline; lower urinary tract symptoms; mouse model; novel therapeutics; operation; palliative; prevent; resilience; response; senescence; sex; side effect; stressor; telomere; translational approach; treatment group; urinary

Project Summary/Abstract Lower urinary tract symptoms (LUTS), including urinary incontinence, overactive and underactive bladder, affect over half of the elderly population and are detrimental to quality of life and independence. Current drug therapies are mostly palliative, suboptimally effective and readily abandoned by patients and prescribers due to undesirable side effects. Urinary control is a complex multi-component operation, with aging representing a major risk factor and potential biological driver of altered voiding and incontinence in older adults. Senescent cells are a cell type which accumulates in aging tissues, releasing a host of chemicals that can impair tissue function. We have found evidence of these cells in bladder tissue. Together with published studies targeting other tissues, this suggests that available drugs aimed at eliminating senescent cells could be the basis for new therapies for urinary disorders associated with aging. In this exploratory project, we will use our aging mouse model to confirm the presence of these cells and study the impact of maturation and aging on their presence in bladder tissues. We will also test the ability of senolytics, drugs that can remove these cells, to reduce senescent cell presence in bladders from old animals. Finally, we will test the ability to maintain or recover youthful bladder function in old age using senolytics using our established aging mouse cystometry model. Our findings will provide important directive and supportive data for future research into the mechanisms of senescent cell involvement with aging and associated dysfunction, and may contribute to new and more effective prevention and treatment for urinary disorders of later life.

项目总结/摘要 下尿路症状（LUTS），包括尿失禁、膀胱过度活动和膀胱活动不足， 影响到一半以上的老年人口，不利于生活质量和独立性。现行药品 治疗大多是姑息性的，效果不佳，并且容易被患者和处方者放弃， 不良副作用。泌尿控制是一个复杂的多组件操作，随着年龄的增长， 老年人排尿改变和尿失禁的主要风险因素和潜在生物驱动因素。衰老 细胞是一种在老化组织中积累的细胞类型，释放出大量可损害组织的化学物质 功能我们已经在膀胱组织中发现了这些细胞的证据。加上已发表的针对 其他组织，这表明，现有的药物，旨在消除衰老细胞可能是基础， 与衰老相关的泌尿系统疾病的新疗法。在这个探索性的项目中，我们将利用我们的老化 小鼠模型，以确认这些细胞的存在，并研究成熟和衰老对它们的影响。 存在于膀胱组织中。我们还将测试抗衰老药物（可以去除这些细胞的药物）的能力， 减少老年动物膀胱中的衰老细胞。最后，我们将测试保持或 使用我们建立的衰老小鼠膀胱测压法，使用senolytics恢复老年人的年轻膀胱功能 模型我们的研究结果将为未来的研究提供重要的指导和支持数据， 衰老细胞参与衰老和相关功能障碍的机制，并可能有助于新的 更有效地预防和治疗晚年的泌尿系统疾病。